Actelion

This study allows people with pulmonary hypertension (high blood pressure in the lungs) to continue receiving their study medications after their original clinical trial ends, if they have no other way to get them. It will track up to 280 participants to monitor the long-term saf…

This program provides access to an investigational drug called selexipag (Uptravi) for patients with Buerger's disease who have wounds that won't heal. Buerger's disease is a rare condition that causes blocked blood vessels, often in the arms and legs, leading to painful sores. T…